Company news
Decision Diagnostics Corp (OTC:DECN) news
Decision Diagnostics Corp news releases on 6ix. Latest, Aug 7, 2018: DECN Makes Its Mark In $1+ Billion Dollar Pet Diabetes & Glucose Testing Market With Two…
Press releases — page 3
DECN Makes Its Mark In $1+ Billion Dollar Pet Diabetes & Glucose Testing Market With Two New Products, Petsure! & Petultimate!
August 6, 2018
Decision Diagnostics Corp. Announces Election of Two Key Managers to the Board of Its Korean Partner ''The Bio Co, Ltd.''
July 11, 2018
Decision Diagnostics (DECN) Contemplates Additional Legal Actions Against Longtime Adversary Johnson & Johnson (JNJ)
April 17, 2018
Decision Diagnostics Discusses Culmination of Patent Case Against J&J and Its Divisions Based on The Federal Doctrine of Equivalents
March 26, 2018
Decision Diagnostics' Panacea Genprecis! Product Moves into Pre-Production, First Round Clinical Trials to Begin in the Next 30 Days
March 20, 2018
Decision Diagnostics' Fundamental Genchoice! Diabetic Test Strip Moves into Formal Managed Clinical Trials and Advanced Testing for Upcoming 510k Filing with U.S. FDA
March 12, 2018
Decision Diagnostics Announces 2018 Business Focus Through the Introduction of New Products, Positive Conclusion to J&J Litigation, and Hybrid Private Label Business Model
January 2, 2018
Decision Diagnostics Provides Additional Commentary About Its New GenAccord!(TM) Diabetic Test Strip
December 19, 2017
Decision Diagnostics Announces New GenAccord!(TM), Diabetic Test Strip with First Use of Its GenPrecis!(TM) Full Spread Electrode Technology
December 13, 2017
Decision Diagnostics Corp. CEO Offers Primary Update on Legal Proceedings, Potential Outcomes, History, and Synopsis on Its Strategic Suit Against J&J
October 31, 2017
Decision Diagnostics Corp. Further Discusses Its Panacea GenPrecis!(TM) Product Just Released into Advanced Development
October 17, 2017
Decision Diagnostics Announces Completion of Feasibility Testing for Their Inspired Genpresis!(TM) Precision Diabetes Glucose Testing System!
October 11, 2017
Decision Diagnostics Announces the Completion of Development and the Onset of Clinical Trials for Its Fundamental Genchoice!(TM) Diabetic Test Strip
October 9, 2017
Patent Litigation Brought by Decision Diagnostics Subsidiaries against Johnson & Johnson/Lifescan Moves Toward Major Ruling
September 20, 2017
Decision Diagnostics Announces the Launch of Its Essential New Gensure!(TM) Diabetic Test Strip for Developing World Markets
September 12, 2017
Decision Diagnostics in Receipt of Revised Cash Offer from Proposed M&A Partner, Enhanced by 21% Over Previously Disclosed Proposals
September 6, 2017
DECN Subsidiaries Plan Rebuttal Brief for Aug. 28th to Debunk J&J/Lifescan's Flawed Legal Reasoning and Factual Misrepresentations in Patent Case
August 23, 2017
Decision Diagnostics Board Reacts Positively to Above-Market Offer From Venture-Funded Company
August 1, 2017
Decision Diagnostics Corp. Receives Surprise Acquisition Offer from Valued Venture Funded Company
July 12, 2017
Retired Decision Diagnostics Chairman, Robert Jagunich, Re-Elected to DECN Board of Directors
June 21, 2017
Decision Diagnostics Chairman and Director Robert Jagunich Retires from DECN Board of Directors
May 30, 2017
DECN Increases Manufacturing Capacity, Opens International Markets for Popular GenUltimate!
December 1, 2016
DECN Litigation Victory Against Johnson + Johnson, Launches Foothold in On-Line Retail Markets for Its Popular "Gen" Products
August 23, 2016
Decision Diagnostics Ends Plans and Communications With Tauriga Sciences, Inc. Concerning Possible Reverse Merger Transaction
July 1, 2016
Decision Diagnostics Emerges Victorious in End to Acrimonious Patent Litigation With Divisions of Johnson + Johnson
June 2, 2016
Decision Diagnostics Nears Positive Ending of Its California Patent and Trademark Infringement Litigation With Divisions of Johnson + Johnson
May 12, 2016
Decision Diagnostics Engages Retail Monster LLC to Procure Big Box Retailers for Company's GenUltimate Product
April 14, 2016
Decision Diagnostics and Subsidiaries Elaborate on the Patent Infringement Lawsuit Against Johnson & Johnson and Two of Its Divisions
March 16, 2016
DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement
March 14, 2016
Decision Diagnostics Conveys Opportunities and Potential Following Landmark Circuit Court Ruling Against Diabetes Testing Division of Johnson & Johnson
February 9, 2016
DECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson
January 28, 2016
Decision Diagnostics Wins Federal Appeals Court Victory, Ruling Affirms J&J Division's Loss of US Patent No. 7,250,105
January 21, 2016
Decision Diagnostics States Johnson & Johnson Division Offers Partial Surrender in Long Running Patent Battle
May 19, 2015
Decision Diagnostics Files Application for Uplisting to OTCMarkets OTCQX
May 12, 2015
Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case
April 21, 2015
U.S. Solicitor General Intervenes Against Johnson & Johnson in DECN's Long Running Patent Battle Over GenStrip 50
April 14, 2015
Johnson & Johnson Division Attempts Final Appeal in Effort to Overturn Multiple USPTO Decisions Issued in DECN's Favor
March 31, 2015
Decision Diagnostics Rejects Settlement Offers From J&J/Lifescan, Company's Prosecutions of Court Bond and Anti-Trust Actions Now Move On
March 4, 2015
DECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials
January 14, 2015
David Defeats Goliath (Again), DECN and Pharma Tech Solutions Awarded Victory Over Johnson & Johnson Lifescan in USPTO Final Ruling
August 11, 2014
DECN's Pharma Tech Subsidiary Places Significant Order for 50,000 Units of Genstrip 50 for Immediate Delivery to Select U.S. and International Distributors
June 3, 2014
Decision Diagnostics Corp. Subsidiary Pharma Tech Enters International Markets With Conformité Européenne (CE) Mark Submission
May 28, 2014